scholarly journals Re: Effect of Sacral Neuromodulation on Female Sexual Function and Quality of Life: Are They Correlated?

2015 ◽  
Vol 2 (2) ◽  
pp. 110-110
Author(s):  
Hüsnü Tokgöz
2011 ◽  
Vol 8 (4) ◽  
pp. 1147-1155 ◽  
Author(s):  
Diego Signorello ◽  
Carl Christian Seitz ◽  
Lucas Berner ◽  
Emanuela Trenti ◽  
Thomas Martini ◽  
...  

2014 ◽  
Vol 8 (11-12) ◽  
pp. 762 ◽  
Author(s):  
Mai Ahmed Banakhar ◽  
Yahya Gazwani ◽  
Mohamed ElKelini ◽  
Tariq Al-shaiji ◽  
Magdy Hassouna

Introduction: Sacral neuromodulation (SNM) has become an established therapy for voiding dysfunction. Additional benefits, such as improved bowel functions and bladder pain, have been reported. Improvement in female sexual function after SNM treatment has been suggested; however, reports examining the effects of SNM on female sexual functions are scarce. We evaluate the effects of SNM on female sexual function and its impact on quality of life and analyze any correlation.Methods: Data were collected from January 2010 to May 2012 for all female patients who underwent SNM InterStim (Medtronic, Minneapolis, MN) therapy at a single centre in Canada. They were treated for voiding dysfunction, including refractory overactive bladder, frequency-urgency syndrome and non-obstructive urinary retention. Patients were screened by percutaneous nerve evaluation (PNE) to assess their response to therapy using a 4-day voiding diary. Patients who experienced 50% or more improvement in their voiding parameters were permanently implanted. All patients completed the Female Sexual Function Index (FSFI), Short-Form Health Survey (SF-36), and incontinence questionnaires (Urinary Distress Inventory [UDI]-6) preoperatively and 4 months postoperatively.Results: A total of 33 female patients had SNM therapy; 10 were excluded from the study because they were not sexually active. The indications were: refractory overactive bladder in 19, frequency urgency syndrome in 2, and non-obstructive urinary retention in another 2 patients. SNM therapy significantly improved the total FSFI score (p = 0.011); the components of desire and orgasm showed significant improvement (p = 0.014 and p = 0.035, respectively). Age, body mass index, diagnosis, and urinary symptoms did not show significant correlation with FSFI score improvement. Quality of life showed significant improvement after SNM treatment in 5 categories. There was no correlation between improvement in quality of life and FSFI.Conclusion: SNM may improve female sexual function and quality of life, yet there is no correlation between the improvement in FSFI and quality of life. 


2011 ◽  
Vol 185 (4S) ◽  
Author(s):  
Mai Banakhar ◽  
Yahya Gazwani ◽  
Mohamed ElKelini ◽  
Tariq Al-shaiji ◽  
Magdy Hassouna

2017 ◽  
Vol 23 (14) ◽  
pp. 1769-1780 ◽  
Author(s):  
Ebru Gozuyesil ◽  
Sule Gokyildiz Surucu ◽  
Sultan Alan

This study aims to evaluate the relationship between the sexual functions and quality of life and the problems during menopausal period. This descriptive, cross-sectional study included a total of 317 women. The mean total Female Sexual Function Index score was 18.8 ± 8.7, while the mean total Sexual Quality of Life Questionnaire-Female score was 72.7 ± 13.7. Sexual dysfunction was found in 82 percent. There was a positive significant correlation between the total Female Sexual Function Index scores and total Sexual Quality of Life Questionnaire-Female scores ( p < 0.05). Our study results suggest that women do not often experience serious menopausal symptoms, but have sexual dysfunction with a moderate sexual quality of life.


2013 ◽  
Vol 16 (3) ◽  
pp. A77
Author(s):  
M. Hock ◽  
S. Tóth ◽  
G. Hartmann ◽  
B. Hajnal ◽  
J. Kránicz ◽  
...  

2020 ◽  

Background and Aim: Obstructive sleep apnea syndrome (OSAS) negatively affects quality of life and causes erectile dysfunction in men. However, there are few studies examining the effects of OSAS on women’s sexual health. This study used validated measurement tools to evaluate whether the presence and severity of OSAS had an impact on female sexual function and if there was a change after 6 months of CPAP treatment. Scores were compared before and after CPAP in the same and between groups. Material and Method: The patients were divided into moderate and severe groups based on the Apnea-Hypopnea Index (AHI). The female patients included in the study were administered the Female Sexual Function Index (FSFI), and the Calgary sleep apnea quality of life index (SAQLI) questionnaires to evaluate their sexual function. After CPAP treatment for 6 months, FSFI, and SAQLI questionnaires were compared with the results before treatment. Results: Among study participants, 72 had severe and 76 had moderate OSAS. The mean age (standard deviation or SD) in the severe OSAS group was 40.97±5.65 years and in the moderate OSAS group was 35.46 ± 5.43 years (p < 0.001). Body mass indexes of the severe and moderate OSAS groups were 33.10 ± 3.33 kg/m2and 31.04 ± 3.42 kg/m2, respectively (p < 0.001). The mean Epworth scores (SD) of the severe and moderate OSAS groups were 11.45 ± 3.27 and 9.52 ± 3.31, respectively (p = 0.001). Based on FSFI scores, in the pre-treatment period, desire, lubrication, and satisfaction were significantly better in the moderate OSAS group. After treatment, only desire and satisfaction were significantly better in the moderate OSAS group. In both groups, after treatment, all parameters of the FSFI score were significantly better compared with the pretreatment values (p = 0.001). When SAQLI scores were compared, in the pre-treatment period, all parameters were significantly better in the moderate OSAS group. In both groups, after treatment, all parameters of the SAQLI score were significantly better compared with the pre-treatment values (p = 0.001). Conclusion: In women with severe and moderate OSAS, sexual functions and satisfaction levels were negatively associated with OSAS severity. Sexual functions and quality of life were significantly improved with effective treatment of OSAS.


2019 ◽  
Vol 20 (1) ◽  
pp. 101
Author(s):  
Laís Figuerêdo Meira ◽  
Karla Cavalcante Silva De Morais ◽  
Nayara Alves De Sousa ◽  
Juliana Barros Ferreira

Introdução: O climatério é um período marcado por transformações no corpo feminino, desse modo, diversos problemas como: redução da lubrificação vaginal, anorgasmia e dispareunia podem surgir ou se agravar e, como consequência, favorece uma diminuição na qualidade de vida. Objetivo: Analisar a relação da função sexual e a qualidade de vida em mulheres climatéricas. Métodos: Trata-se de um estudo observacional, de corte transversal, analítico. A coleta de dados foi realizada com 20 mulheres climatéricas com faixa etária de 38 a 60 anos. Como instrumentos foram utilizados questionários contendo dados sociodemográficos, o Female Sexual Function Index para avaliar a função sexual e o World Health Organization Quality of Life WHOQOL-BREF para analisar a qualidade de vida. Resultados: Foi observado que nas mulheres que possuem disfunção sexual no domínio excitação, a média está abaixo do ponto de corte, o que não ocorre com mulheres que não possuem disfunção (p = 0,03), o mesmo ocorre com os domínios orgasmo e satisfação. Na correlação da função sexual com a qualidade de vida, há significância estatística nos domínios físico (p = 0,023) e meio ambiente (p = 0,049). Conclusão: Constatou-se que nas mulheres que possuem uma qualidade de vida reduzida os impactos da disfunção sexual são maiores.Palavras-chave: climatério, menopausa, mulheres, saúde sexual, qualidade de vida.


Sign in / Sign up

Export Citation Format

Share Document